Steve Schonfeld’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$617K Buy
+2,649
New +$612K ﹤0.01% 1865
2025
Q3
– Sell
-25,389
Closed -$4.56M – 2273
2025
Q2
$4.56M Buy
25,389
+8,366
+49% +$1.45M 0.03% 596
2025
Q1
$2.88M Sell
17,023
-2,077
-11% -$341K 0.02% 773
2024
Q4
$2.88M Sell
19,100
-15,400
-45% -$2.4M 0.02% 696
2024
Q3
$5.36M Buy
34,500
+22,740
+193% +$3.4M 0.04% 521
2024
Q2
$1.61M Buy
+11,760
New +$1.61M 0.01% 1002
2023
Q4
– Sell
-24,618
Closed -$3M – 1936
2023
Q3
$3M Buy
+24,618
New +$3.28M 0.02% 702
2023
Q2
– Sell
-8,417
Closed -$1.19M – 2214
2023
Q1
$1.19M Sell
8,417
-8,448
-50% -$1.21M 0.01% 882
2022
Q4
$2.64M Buy
16,865
+1,964
+13% +$282K 0.02% 709
2022
Q3
$1.83M Buy
14,901
+3,639
+32% +$479K 0.02% 909
2022
Q2
$1.5M Sell
11,262
-45,238
-80% -$6.16M 0.01% 842
2022
Q1
$7.73M Buy
56,500
+50,339
+817% +$7.02M 0.07% 324
2021
Q4
$1.07M Sell
6,161
-3,939
-39% -$599K 0.01% 905
2021
Q3
$1.47M Buy
+10,100
New +$1.48M 0.02% 817
2021
Q1
– Sell
-18,130
Closed -$2.16M – 1862
2020
Q4
$2.16M Sell
18,130
-32,312
-64% -$3.94M 0.03% 582
2020
Q3
$5.78M Buy
50,442
+32,466
+181% +$3.84M 0.11% 254
2020
Q2
$2.05M Sell
17,976
-4,590
-20% -$487K 0.05% 398
2020
Q1
$1.81M Buy
22,566
+7,652
+51% +$792K 0.11% 214
2019
Q4
$1.59M Sell
14,914
-18,186
-55% -$1.9M 0.04% 384
2019
Q3
$3.54M Buy
+33,100
New +$3.4M 0.1% 211
2018
Q4
– Sell
-3,500
Closed -$378K – 1097
2018
Q3
$378K Sell
3,500
-1,320
-27% -$145K 0.02% 641
2018
Q2
$530K Buy
+4,820
New +$502K 0.03% 527
2018
Q1
– Sell
-3,754
Closed -$370K – 801
2017
Q4
$370K Sell
3,754
-55,432
-94% -$5.25M 0.03% 534
2017
Q3
$5.54M Buy
59,186
+43,310
+273% +$4.6M 0.51% 55
2017
Q2
$1.76M Buy
+15,876
New +$1.68M 0.18% 172

Other funds holding DGX

Steve Schonfeld's DGX Position: Q3 2026 in Review

Steve Schonfeld opened a new position in Quest Diagnostics (DGX) in Q3 2026: 2,649 shares worth $617K. The stake represents ﹤0.01% of the portfolio and ranks #1865 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in DGX as recently as Q2 2025.

Steve Schonfeld first reported a position in DGX in Q2 2017 and has held it in 25 quarters since. The position peaked at $7.73M in Q1 2022. 1,142 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • Steve Schonfeld held 2,649 shares of Quest Diagnostics worth $617K as of Q3 2026.
  • Quest Diagnostics was a new Steve Schonfeld position in Q3 2026.
  • Quest Diagnostics made up ﹤0.01% of Steve Schonfeld's portfolio in Q3 2026, its #1865 holding.
  • Steve Schonfeld first reported a position in Quest Diagnostics in Q2 2017 and has held it in 25 quarters since.
  • Steve Schonfeld's Quest Diagnostics position peaked at $7.73M in Q1 2022.
  • 1,142 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.